Form 8-K - Current report:
SEC Accession No. 0000950170-23-014099
Filing Date
2023-04-24
Accepted
2023-04-24 16:23:43
Documents
12
Period of Report
2023-04-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bttx-20230424.htm   iXBRL 8-K 49840
  Complete submission text file 0000950170-23-014099.txt   169623

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bttx-20230424_pre.xml EX-101.PRE 10230
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bttx-20230424.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bttx-20230424_lab.xml EX-101.LAB 13904
6 EXTRACTED XBRL INSTANCE DOCUMENT bttx-20230424_htm.xml XML 4860
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 23840388
SIC: 8000 Services-Health Services